|
|
||||||||
Published online before print August 3, 2006
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Article |
,
Departments of *Infectious, Parasitic and Immune-Mediated Diseases and
Drug Research and Evaluation, Istituto Superiore di Sanità, Rome, Italy
@ To whom correspondence should be addressed. E-mail: vendetti{at}iss.it.
| Abstract |
|---|
We have previously shown that cholera toxin (CT) and other cAMP-elevating agents induce up-regulation of the inhibitory molecule CTLA-4 on human resting T lymphocytes. In this study, we evaluated the function of these cells. We found that purified human CD4+ T PBMC in a dose-dependent manner. It is interesting that this phenomenon was not mediated by inhibitory cytokines such as IL-10, IL-4, or TGF-
but was in part caused by the release of extracellular cAMP by the CD4+ T lymphocytes. Purified CD4+ T cells pretreated with forskolin, a transient cAMP inducer, or with dibutyryl cAMP, an analog of cAMP, did not exert suppressive functions, suggesting that a sustained production of cAMP, such as that induced by CT, was required to identify a novel, regulatory function mediated by CD4+ T cells. Our results show that CD4+ T lymphocytes can exert regulatory functions through the release of extracellular cAMP and that the cyclic nucleotide acts as a primary messenger, which could play a biological role in the modulation of immune responses.
Key Words: T cells suppression cholera toxin
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |